Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | +1.51% | -2.58% |
02-02 | Novozymes, Chr. Hansen Complete Merger Settlement | MT |
02-02 | Chr. Hansen Holding A/S(CPSE:CHR) dropped from OMX Nordic All-Share Index | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- The company is in debt and has limited leeway for investment
- Based on current prices, the company has particularly high valuation levels.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.58% | 10.54B | - | ||
+0.13% | 29.22B | B- | ||
+23.12% | 25.46B | B | ||
+4.67% | 11.06B | B- | ||
+15.10% | 5.27B | C- | ||
+18.43% | 4.47B | B+ | ||
-8.30% | 3.83B | C | ||
+2.12% | 3.4B | B+ | ||
+0.07% | 2.99B | C+ | ||
+25.54% | 2.79B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- CHR Stock
- 51C Stock
- Ratings Christian Hansen